The purpose of this meta-analysis was to assess the health-related quality of life (HRQoL) of living kidney donors using the 36-item Medical Outcomes Short-Form-36 questionnaire (SF-36). A systematic search of the Web of Science, PubMed, Embase, Elsevier/ScienceDirect, Wanfang, Weipu, and China National Knowledge Infrastructure databases for studies that used the SF-36 to evaluate the HRQoL of living kidney donors up to April 2020 was performed. Stata version 12.0 (StataCorp LLC, College Station, TX, USA) was used for meta-analysis. In all, nine studies comprising 802 living kidney donors were included in this meta-analysis. The research revealed that living kidney donors were inferior in physical health to the general population with regard to bodily pain (BP), superior to the general population in terms of general health (GH), and exhibited no significant difference from the general population in physical function (PF) and role-physical (RP). In the case of psychological health, living kidney donation had a positive impact on well-screened living kidney donors. Based on our results, clinicians can inform potential kidney donors that there is a low risk in donating a kidney, which contributes to provide guidance to design counseling interventions for both kidney recipients and donors.

Download full-text PDF

Source
http://dx.doi.org/10.1080/13548506.2020.1856392DOI Listing

Publication Analysis

Top Keywords

living kidney
28
kidney donors
28
general population
12
kidney
10
health-related quality
8
quality life
8
donors
8
donors 36-item
8
36-item medical
8
medical outcomes
8

Similar Publications

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct effects of these drugs is the subject of intense interest. Although reductions in major adverse cardiovascular events appear to be predominantly driven by the direct tissue effects of such drugs, the associated weight loss effects must be relevant to the benefits observed in other major outcomes, albeit to differing extents. In this Personal View, we draw on evidence to support that weight loss is at least partly responsible (albeit to differing extents) for the reported benefits of incretin-based drugs for obesity in people living with heart failure with preserved ejection fraction, hypertension, chronic kidney disease, and type 2 diabetes.

View Article and Find Full Text PDF

Background: Prior studies indicate that 1% to 4% of Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R-) kidneys develop posttransplant lymphoproliferative disorder (PTLD). However, these estimates are based on limited data that lack granularity.

Objective: To determine the associations between pretransplant EBV D+/R- and recipient EBV-seropositive status (R+) and the outcomes of PTLD and graft and patient survival among adult kidney transplant recipients.

View Article and Find Full Text PDF

Living-donor kidney transplantation is the preferred treatment for kidney failure. In the United States, rates of living kidney donation have been stagnant, which is partly related to concerns over medical and financial risks. Recent research has better characterized the risks of living kidney donation, although the field is limited by a lack of robust registries.

View Article and Find Full Text PDF

Optimizing the long-term care and follow-up of living kidney donors (LKDs) has been challenging, and prior LKDs have reported suboptimal healthcare experiences. Long-term care of LKDs is largely undertaken by primary care practitioners such as family physicians (FPs). We conducted a cross-sectional survey of Canadian FPs (n = 151).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!